Skip to main content

Abbott Laboratories Investors File Lawsuit Against Directors Alleging Breaches Of Fiduciary Duties

  • If you purchased shares of Abbott Laboratories (NYSE: ABT), and / or if you have any information relating the investigation including those who are former employees or/and whistleblowers, you may have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

San Diego, Nov. 28, 2011 (Shareholders Foundation) -- An investor in NYSE ABT shares filed a lawsuit against directors of Abbott Laboratories (NYSE: ABT) over alleged breaches of fiduciary duty in connection with alleged off-label marketing of Depakote that cost Abbott Laboratories $1.3billion settlement with the US Government and 24 states. According to the complaint the plaintiff a...

You must register (for free) or login to view the entire case.